Nisa Investment Advisors LLC raised its holdings in Corteva, Inc. (NYSE:CTVA – Free Report) by 0.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 220,134 shares of the company’s stock after buying an additional 845 shares during the period. Nisa Investment Advisors LLC’s holdings in Corteva were worth $12,942,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently made changes to their positions in CTVA. Anomaly Capital Management LP bought a new position in shares of Corteva in the second quarter valued at $188,578,000. Vaughan Nelson Investment Management L.P. lifted its stake in shares of Corteva by 392.3% in the second quarter. Vaughan Nelson Investment Management L.P. now owns 4,083,685 shares of the company’s stock valued at $220,274,000 after buying an additional 3,254,126 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in shares of Corteva by 28.4% in the second quarter. Bank of New York Mellon Corp now owns 6,842,907 shares of the company’s stock valued at $369,106,000 after buying an additional 1,514,954 shares in the last quarter. Panagora Asset Management Inc. lifted its stake in shares of Corteva by 700.2% in the second quarter. Panagora Asset Management Inc. now owns 1,301,996 shares of the company’s stock valued at $70,230,000 after buying an additional 1,139,297 shares in the last quarter. Finally, Natixis Advisors LLC lifted its stake in shares of Corteva by 155.7% in the second quarter. Natixis Advisors LLC now owns 1,694,214 shares of the company’s stock valued at $91,389,000 after buying an additional 1,031,678 shares in the last quarter. 81.54% of the stock is owned by institutional investors.
Corteva Price Performance
CTVA opened at $60.80 on Wednesday. The company has a market capitalization of $42.38 billion, a price-to-earnings ratio of 76.96, a PEG ratio of 1.66 and a beta of 0.77. The company has a quick ratio of 1.17, a current ratio of 1.72 and a debt-to-equity ratio of 0.10. The firm has a 50-day moving average price of $57.41 and a 200-day moving average price of $55.24. Corteva, Inc. has a twelve month low of $43.22 and a twelve month high of $61.38.
Corteva Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Monday, December 2nd will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.12%. Corteva’s dividend payout ratio (DPR) is currently 86.08%.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on CTVA. Morgan Stanley reiterated an “overweight” rating and issued a $65.00 target price on shares of Corteva in a report on Tuesday, September 24th. Citigroup began coverage on shares of Corteva in a report on Wednesday, October 23rd. They issued a “buy” rating and a $68.00 target price for the company. Wells Fargo & Company lowered their target price on shares of Corteva from $67.00 to $65.00 and set an “overweight” rating for the company in a report on Friday, August 2nd. JPMorgan Chase & Co. lowered their target price on shares of Corteva from $57.00 to $55.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. Finally, Bank of America upgraded shares of Corteva from a “neutral” rating to a “buy” rating and increased their target price for the company from $59.00 to $67.00 in a report on Wednesday, October 16th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and a consensus target price of $62.84.
Check Out Our Latest Analysis on CTVA
Corteva Profile
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Recommended Stories
- Five stocks we like better than Corteva
- What Are Dividend Champions? How to Invest in the Champions
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- What is the Nasdaq? Complete Overview with History
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.